Free delivery on orders over £40 Oral weight loss is here UK-registered prescribers, GPhC regulated Free delivery on orders over £40 Oral weight loss is here UK-registered prescribers, GPhC regulated Free delivery on orders over £40 Oral weight loss is here UK-registered prescribers, GPhC regulated

A Complete Guide to Mounjaro Doses For Those Starting Medicated Weight Loss in 2026

Date: 31 / Mar / 2026

Starting medicated weight loss in 2026 means having access to some of the most clinically advanced treatments available. Mounjaro has rapidly become one of the most discussed weight loss medications in the UK, and for good reason – clinical trials have shown it to be highly effective when used correctly and supported by proper clinical care.

But one of the most common questions patients ask before starting is simply: how does the dosing actually work? This guide walks through everything you need to know about Mounjaro doses, from the very first injection to the maintenance stage, in a clear and straightforward way.

If you are ready to find out whether you are eligible, complete our online consultation form or get in touch with our clinical team.

Start Consultation

This article is intended for general information purposes only and does not replace personalised clinical advice from a qualified prescriber.

1. What Is Mounjaro And How Does It Work?

Mounjaro contains tirzepatide, a dual-action medication that works by mimicking two naturally occurring hormones — GLP-1 and GIP — that are released after eating. These hormones signal to the brain that the body is full, slow digestion, and help regulate blood sugar levels.

This dual mechanism is what sets Mounjaro apart from earlier generation weight loss medications. According to the SURMOUNT-1 trial published in The Lancet, participants taking the highest dose of tirzepatide lost an average of 22.5% of their body weight over 72 weeks — a result that has made it one of the most effective weight loss medications studied to date.

It is administered as a once-weekly subcutaneous injection, typically into the abdomen, thigh, or upper arm.

2. Why Mounjaro Uses A Gradual Dosing Schedule

Mounjaro is not started at its full therapeutic dose. Instead, it follows a structured titration schedule that begins low and increases gradually over several months. This approach exists for good reason:

• it allows the body time to adjust to the medication
• it significantly reduces the likelihood and severity of side effects
• it gives clinicians the opportunity to assess tolerability before each increase
• it helps establish sustainable habits alongside the medication

Patients who understand the purpose of titration are far better prepared for the early weeks of treatment, when results may be modest but the groundwork is being laid for more significant progress ahead.

Weight loss dose tracking in calendar

3. The Full Mounjaro Dose Schedule At A Glance

Mounjaro is available in six doses, introduced at four-week intervals. Not every patient will progress to the highest dose — the goal is to find the dose at which weight loss is effective and well tolerated, not simply to reach 15mg as quickly as possible.

Here is the standard titration schedule:

• Weeks 1–4: 2.5mg — the introductory dose, focused on adjustment
• Weeks 5–8: 5mg — the first therapeutic increase
• Weeks 9–12: 7.5mg — appetite suppression typically becomes more noticeable
• Weeks 13–16: 10mg — meaningful weight loss typically established by this stage
• Weeks 17–20: 12.5mg — approaching the maintenance range
• Week 21 onwards: 15mg — maximum maintenance dose for those who tolerate it

Each increase is subject to clinical review. If a patient experiences side effects at a particular dose, it may be appropriate to remain at that level for longer before progressing.

4. What To Expect At Each Dose Stage

Understanding what each dose stage typically feels like helps set realistic expectations and reduces unnecessary concern when the body responds to changes.

2.5mg (Weeks 1–4)
This is a gentle introductory dose. Most patients notice very little change in appetite at this stage, which is entirely normal. The body is simply beginning to adjust. Side effects, if any, are usually mild.

5mg (Weeks 5–8)
Appetite suppression often begins to become noticeable here. Some patients report feeling satisfied with smaller meals and less inclined to snack. Early weight loss may begin to appear on the scales.

7.5mg (Weeks 9–12)
For many patients this is the dose where treatment begins to feel genuinely effective. Cravings typically reduce and portion sizes naturally decrease. This is also the stage where it becomes important to ensure protein and nutrient intake remains adequate despite reduced appetite.

10mg–15mg (Weeks 13 onwards)
These doses represent the therapeutic range where the most significant weight loss tends to occur. Patients often report that food noise — the persistent mental preoccupation with eating — reduces considerably at these stages.

5. Side Effects By Dose: What Is Normal And What Is Manageable

Side effects are one of the most common concerns for patients starting Mounjaro. The reassuring reality is that the majority of side effects are mild, tend to be most noticeable in the early stages of each dose increase, and usually settle within a week or two as the body adjusts.

The table below outlines what is commonly experienced at each stage, along with practical context.

Dose StageCommonly Reported Side EffectsHow Long They Typically LastReassuring Context
2.5mgMild nausea, slight fatigueA few days after first injectionVery common and short-lived as the body begins to adjust
5mgNausea, reduced appetite, loose stools3–7 days after dose increaseUsually settles quickly; eating smaller, blander meals can help
7.5mgNausea, indigestion, constipation or loose stoolsUp to 1–2 weeks after increaseStaying well hydrated and eating slowly makes a noticeable difference
10mgNausea, burping, reduced appetiteTypically settles within 1–2 weeksMost patients find side effects lessen as the body adapts to this dose
12.5mgMild nausea, fatigue, digestive changesA few days to a weekBy this stage many patients are experienced at managing early-dose symptoms
15mgSimilar to 12.5mg; usually well toleratedBrief adjustment periodPatients reaching this dose are typically well adapted to the medication

Side effect experiences vary between individuals. If you experience persistent, severe, or concerning symptoms at any dose, contact your clinical team. This table is for general informational purposes only.

man flex healthy eating

6. How To Support Your Body Through Each Dose Increase

A few simple habits can make each dose increase considerably more comfortable:

• eat smaller meals more slowly, particularly in the days following a new dose
• avoid rich, fatty, or heavily spiced foods in the early days after an increase
• stay well hydrated throughout the day
• take your injection on a day when you do not have demanding commitments the following morning
• prioritise protein at each meal to support muscle retention alongside fat loss

These adjustments are not permanent. Most patients find that after the first week or two at a new dose, their body adapts and these measures are no longer necessary.

7. Does Everyone Need To Reach The Highest Dose?

No — and this is an important point that is often misunderstood. The goal of titration is not to reach 15mg for its own sake. It is to find the dose at which weight loss is meaningful and well tolerated for each individual patient.

Some patients achieve excellent results at 10mg or 12.5mg and have no clinical reason to increase further. Others may benefit from progressing to 15mg to maximise results. This decision is always made in consultation with a clinician based on individual progress and tolerability.

Frequently Asked Questions

How Long Does It Take To See Results On Mounjaro?

Most patients begin to notice appetite changes from around the 5mg dose onwards. Visible weight loss on the scales typically becomes consistent from weeks eight to twelve, with more significant results building through the higher dose stages.

What Happens If I Cannot Tolerate A Dose Increase?

If side effects at a particular dose are difficult to manage, it is appropriate to remain at the previous dose for longer before attempting to increase again. Your clinical team can advise on the best approach based on your experience.

Can I Stay On A Lower Dose Permanently?

Yes, if that dose is delivering safe and effective weight loss. Dose decisions are always made individually and are not a one-size-fits-all process. A higher dose is not automatically better if a lower one is working well for you.

Is Mounjaro Suitable For Me?

Eligibility is assessed through a clinical consultation. Mounjaro is generally suitable for adults with a BMI of 30 or above, or 27 and above with weight-related health conditions. Certain medical histories may affect suitability. Complete our online consultation form to find out.

How Is Mounjaro Different From Wegovy?

Wegovy contains semaglutide, a GLP-1 receptor agonist. Mounjaro contains tirzepatide, which activates both GLP-1 and GIP receptors. This dual action is associated with greater average weight loss in clinical trials, though individual responses vary.

How Do I Get Started With Mounjaro Through Everslim?

Complete our online consultation form and our clinical team will review your health information and eligibility. If approved, medication is prescribed and delivered directly to your home with clear guidance on how to begin.

Ready To Begin Your Journey?

Starting Mounjaro in 2026 means benefiting from a well-established, clinically supported treatment pathway. With the right expectations, proper clinical oversight, and a gradual approach to dosing, the majority of patients find the process far more manageable than they initially feared.

At Everslim, our clinical team is with you from your first consultation to your maintenance dose and beyond. If you are ready to take the first step, complete our online consultation form today or contact us if you have questions before getting started.

Start Consultation

Clinically Reviewed

Medically and clinically reviewed by the Superintendent Pharmacist

Muhammad Mian MPharmS IP

Independent Prescribing Pharmacist

GPhC Registration Number: 2066548

Muhammad Mian is our Sales and Commercial Director at Everslim, as well as an experienced Independent Prescribing Pharmacist. With over 20 years in the healthcare sector, he combines deep clinical expertise with strategic insight to help drive safe, effective and personalised weight loss journeys for our patients.

All medical content on this page is reviewed for clinical accuracy, regulatory compliance and alignment with current UK prescribing standards.

Last reviewed: March 2026

Ready to Take the Next Step? Start Your Weight Loss Journey Today!

Take our short 5 minute questionnaire now.